
FERTILYSIS, specializes in the investigation and treatment of unexplained infertility and recurrent miscarriages, providing answers where standard practices fail.
We’ve expanded our KIR–HLA compatibility testing to include maternal HLA-C typing alongside paternal HLA-C. This update provides a more complete immune compatibility evaluation and reflects our commitment to moving beyond standard. New evidence shows that maternal HLA-C matters too. That’s why we’ve added it to our KIR–HLA testing — delivering a more comprehensive and clinically meaningful assessment for immune-related fertility risks.
Page 2 of 6

FERTILYSIS, specializes in the investigation and treatment of unexplained infertility and recurrent miscarriages, providing answers where standard practices fail.